BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7692689)

  • 21. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical carcinoma in situ associated with azathioprine therapy. A case report and literature review.
    Balachandran I; Galagan KS
    Acta Cytol; 1984; 28(6):699-702. PubMed ID: 6391055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
    Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
    Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal cervical cytology in pregnancy: a 17-year experience.
    Economos K; Perez Veridiano N; Delke I; Collado ML; Tancer ML
    Obstet Gynecol; 1993 Jun; 81(6):915-8. PubMed ID: 8497355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of cytological screening for cancers and precancerous lesions of the cervix].
    Boman F; Duhamel A; Trinh QD; Deken V; Leroy JL; Beuscart R
    Bull Cancer; 2003 Jul; 90(7):643-7. PubMed ID: 12957806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear.
    Higgins RV; Hall JB; McGee JA; Laurent S; Alvarez RD; Partridge EE
    Obstet Gynecol; 1994 Aug; 84(2):174-8. PubMed ID: 8041525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Are analyses of cytological cervix smears from young women more harmful than beneficial?].
    Skjeldestad FE; Hagen B; Hagmar B; Iversen OE; Juvkam KH; Steen R; Thoresen S; Hareide B
    Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1782-5. PubMed ID: 17599128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [CIN--what influence do smoking and socioeconomic factors have?].
    Barten G
    Zentralbl Gynakol; 1991; 113(17):923-6. PubMed ID: 1746190
    [No Abstract]   [Full Text] [Related]  

  • 29. Risk of invasive cervical cancer after three consecutive negative Pap smears.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Premalignant and malignant changes in the uterine cervix in women younger than 30 years].
    Postruznik S; Jurić M; Giljanović L; Strmo V
    Jugosl Ginekol Perinatol; 1985; 25(5-6):121-4. PubMed ID: 3837134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Colpocytological patterns caused by hormonal contraceptives].
    Pescetto G; Ragni N
    Minerva Ginecol; 1975 Jun; 27(6):433-9. PubMed ID: 1153120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of the ThinPrep monolayer technique and conventional cervical Pap smears in a high-risk population using the Munich II nomenclature].
    Lellé RJ; Cordes A; Regidor M; Maier E; Flenker H
    Gynakol Geburtshilfliche Rundsch; 2007; 47(2):81-7. PubMed ID: 17440269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The significance of documenting clinical appearance of the uterine cervix in the cervical cytology form.
    Al-Kadri HM; Hajeer AH; Al-Hawashim NS; Salem HH
    Saudi Med J; 2006 Nov; 27(11):1698-702. PubMed ID: 17106544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Follow-up of women with mild cellular changes in the cervix].
    Bichel P
    Ugeskr Laeger; 2003 May; 165(21):2181. PubMed ID: 12820503
    [No Abstract]   [Full Text] [Related]  

  • 35. Frequency of cervical smear abnormalities within 3 years of normal cytology.
    Dyson RD
    Obstet Gynecol; 2000 Dec; 96(6):1026. PubMed ID: 11203354
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hormonally induced changes of the portio caused by ovulation inhibitors].
    Guhr O
    Munch Med Wochenschr; 1972 Apr; 114(16):766-8. PubMed ID: 5067884
    [No Abstract]   [Full Text] [Related]  

  • 37. Observations on the development of dysplasia.
    Heinzl S; Szalmay G; Jochum L; Roemer V
    Acta Cytol; 1982; 26(4):453-6. PubMed ID: 6957097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency and diagnostic reliability of subvisual morphologic markers for malignancy in the cervical epithelium.
    Haroske G; Bergander S; König R
    Arch Geschwulstforsch; 1988; 58(3):159-68. PubMed ID: 3415434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mesonephroid hyperplasia of the uterine cervix].
    Rosen A; Klein M; Preiser J
    Pathologe; 1992 Apr; 13(2):114-6. PubMed ID: 1603773
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cyto-histological investigation of abnormal portio and cervix uteri findings with regard to exogenous hormones (author's transl)].
    Herting W; Schnell JD
    Verh Dtsch Ges Pathol; 1973; 57():234-7. PubMed ID: 4142183
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.